(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
Introducing the new Bone Marrow Failure Syndromes Panel (59 genes)
NGS panels are also available for:
> Download the Guide for Clinicians for detailed information.
Next-generation sequencing (NGS) is a method of sequencing multiple genes at one time. Unlike traditional Sanger sequencing, NGS involves randomly fragmenting a patient's DNA, sequencing these fragments, and bioinformatically fitting the pieces back together.
NGS is more efficient and economical than Sanger sequencing if more than one or two genes are being tested at once. It is important to note that any genetic testing can result in uncertain findings (variants of uncertain clinical significance) and a test that sequences more genes will identify more of these variants.
NGS panels that test multiple genes associated with a given phenotype are particularly valuable when a condition is suspected but the responsible gene is unknown. When a certain gene is strongly suspected, Sanger sequencing of that gene may be a better choice. When a specific mutation has been identified in a family, targeted mutation analysis is the best option.
To discuss testing strategies for a specific patient, call 513-636-4474 and ask to speak with a genetic counselor.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center